Clinical Trial Update: Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A two-part Phase 1/2 trial of BIW-8962 as monotherapy in lung cancer has been terminated; the study evaluated Non-Small Cell Lung Cancer, Small Cell Lung Cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• BIW-8962 (BIW-8962)

Snippet

Sponsor: Kyowa Kirin Korea Co., Ltd. | Conditions: Phase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma, Phase 2 Portion : Small Cell Lung Cancer(SCLC) | Phase 1, Phase 2 | Status: TERMINATED